You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch.
You may also report side effects to Genentech at (888) 835-2555.
VENCLEXTA is indicated:
Tumor Lysis Syndrome
Increased Mortality in Patients with Multiple Myeloma when VENCLEXTA is Added to Bortezomib and Dexamethasone
Females and Males of Reproductive Potential
Please see full Prescribing Information.
Venclexta® is the subject of a Collaboration Agreement between AbbVie Inc. and Genentech, Inc.